The Financial Times and PBS have debuted “Opioids Inc.,” a combined investigation into the role one pharmaceutical company played in fueling America’s epidemic of opioid addiction, and how it and its stockholders profited from it.
This is the first-ever collaboration between “Frontline” and the FT, while demonstrating the latter’s continued investment to engage audiences in the U.S.
The joint investigation launches with a free, in-depth magazine cover story from the FT, followed by streaming of the “Opioids Inc.” documentary and concluding with a television debut on PBS “Frontline” on June 23.
“‘Opioids Inc.’ is a deeply investigated collaboration between two influential news organisations into a story about corporate misconduct and its social ramifications,” said Kayode Josiah, director of commercial development at the FT. “This partnership allows the FT to further its presence in the US while leveraging both its world class journalism and the strength of a trusted brand that is PBS.”
“Opioids Inc.” can be watched in full at pbs.org/frontline and in the PBS Video App for American audiences. It will also be available online for two weeks for viewers in U.K.
The Star Tribune is seeking an accomplished, motivated and versatile journalist and leader to shape…
The Deputy AME-Business is responsible for the development and planning of coverage on all Newsday…
CNBC.com managing editor Jeff McCracken announced Friday the following promotions: In San Francisco, Ari Levy has…
This Newsday reporter will cover Long Island’s commercial real estate market and the region’s evolving…
The New York Times is looking for a versatile editor to edit enterprise and feature…
International editor Matt Lamers is leaving Marijuana Business Daily. He has been there for seven years. Lamers…